Related Experiment Video
Updated: Aug 26, 2026

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
Published on: August 23, 2022
Hepatic function and physiology in the newborn
1The Liver Unit, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
Insights
Liver development is complex, with full maturity achieved two years post-birth. Neonatal liver dysfunction risks include immaturity, hypoxia, and sepsis, with potential links to fatty liver disease.
Area of Science:
- Hepatology
- Developmental Biology
- Neonatal Medicine
Background:
- Liver development progresses from progenitor cells, with bile secretion by 12 weeks' gestation.
- Hepatocyte specialization occurs at birth, with distinct sinusoidal and canalicular surfaces for nutrient absorption and bile/metabolite transport.
- Postnatal interruption of umbilical supply rapidly induces key liver functions like transamination and coagulation factor synthesis.
Purpose of the Study:
- To review liver development from progenitor cells to mature organ.
- To highlight functional and anatomical specialization of the liver acinus.
- To discuss risks and causes of neonatal liver dysfunction and potential long-term implications.
Main Methods:
- Literature review of liver development and function.
- Discussion of signaling pathways (e.g., JAG1) and genetic factors.
- Analysis of neonatal liver risks and emerging concepts like neonatal fatty liver disease.
Main Results:
- Liver maturity is achieved up to two years after birth, involving complex signaling pathways.
- Hepatocytes exhibit specialized functions and anatomical zonation (Zones 1, 2, 3) within the hepatic acinus.
- Preterm infants face increased risks of hepatic decompensation due to immature detoxifying and synthetic functions.
Conclusions:
- Neonatal liver immaturity, hypoxia, and sepsis are significant causes of liver dysfunction.
- Stem cell and genetic research offer insights into liver development and regeneration.
- The neonatal period may be critical for the development of conditions like non-alcoholic steatohepatitis (NASH).
Abstract:
The liver develops from progenitor cells into a well-differentiated organ in which bile secretion can be observed by 12 weeks' gestation. Full maturity takes up to two years after birth to be achieved, and involves the normal expression of signalling pathways such as that responsible for the JAG1 genes (aberrations occur in Alagille's syndrome), amino acid transport and insulin growth factors. At birth, hepatocytes are already specialized and have two surfaces: the sinusoidal side receives and absorbs a mixture of oxygenated blood and nutrients from the portal vein; the other surface delivers bile and other products of conjugation and metabolism (including drugs) to the canalicular network which joins up to the bile ductules. There is a rapid induction of functions such as transamination, glutamyl transferase, synthesis of coagulation factors, bile production and transport as soon as the umbilical supply is interrupted. Anatomical specialization can be observed across the hepatic acinus which has three distinct zones. Zone 1 borders the portal tracts (also known as periportal hepatocytes) and is noted for hepatocyte regeneration, bile duct proliferation and gluconeogenesis. Zone 3 borders the central vein and is associated with detoxification (e.g. paracetamol), aerobic metabolism, glycolysis and hydrolysis and zone 2 is an area of mixed function between the two zones. Preterm infants are at special risk of hepatic decompensation because their immaturity results in a delay in achieving normal detoxifying and synthetic function. Hypoxia and sepsis are also frequent and serious causes of liver dysfunction in neonates. Stem cell research has produced many answers to the questions about liver development and regeneration, and genetic studies including studies of susceptibility genes may yield further insights. The possibility that fatty liver (increasingly recognized as non-alcoholic steatohepatitis or NASH) may have roots in the neonatal period is a concept which may have important long-term implications.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Pharmacokinetics in Pediatric Patients: Drug Distribution

